 WORCESTER, Mass., Sept. 30, 2021 GLOBE NEWSWIRE -- Mustang Bio, Inc. Mustang NASDAQ: MBIO, a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, and members of the Mustang Leadership Team will participate in a fireside chat at Chardans Virtual 5th Annual Genetic Medicines Conference, taking place on Tuesday, October 5, 2021, at 8:00 a.m. ET. The company will also participate in one-on-one meetings during the conference. A live webcast of the companys chat will be available on the Events page of the Investor Relations section of Mustangs website, for approximately 30 days after the meeting. 